TELA Bio, Inc. - stock earnings

TELA Quarterly earnings

DateEarningsRevenue
2023Q3 -11.0 million USD 15.1 million USD
2023Q2 -10.8 million USD 14.5 million USD
2023Q1 -14.0 million USD 11.9 million USD
2022Q4 -9.8 million USD 11.6 million USD
2022Q3 -11.9 million USD 11.2 million USD
2022Q2 -13.3 million USD 10.4 million USD
2022Q1 -11.9 million USD 8.2 million USD
2021Q4 -8.6 million USD 8.4 million USD
2021Q3 -8.3 million USD 7.7 million USD
2021Q2 -8.3 million USD 7.6 million USD
2021Q1 -8.1 million USD 5.9 million USD
2020Q4 -7.8 million USD 5.7 million USD
2020Q3 -7.7 million USD 5.3 million USD
2020Q2 -6.1 million USD 3.5 million USD
2020Q1 -7.2 million USD 3.7 million USD
2019Q4 -6.5 million USD 4.9 million USD
2019Q3 -4.7 million USD 4.0 million USD
2019Q2 -5.3 million USD 3.3 million USD
2019Q1 -6.0 million USD 3.3 million USD
2018Q4 -7.4 million USD 2.4 million USD
2018Q3 -2.8 million USD 2.2 million USD

TELA Yearly earnings

DateEarningsRevenue
2023 -43.8 million USD 53.1 million USD
2022 -44.3 million USD 41.4 million USD
2021 -36.1 million USD 29.5 million USD
2020 -31.9 million USD 18.2 million USD
2019 -25.8 million USD 15.4 million USD
2018 -21.1 million USD 8.3 million USD
2017 -21.3 million USD 4.2 million USD

TELA

Price: $4.72

52 week price:
4.24
11.61

Earnings Per Share: -2.04 USD

P/E Ratio: -3.52

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Volume: 32300

Market Capitalization: 131.1 million

Links: